BIMINI Biotech Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $3.13M

  • Investors
  • 10

BIMINI Biotech General Information

Description

Developer of small-molecule therapeutics designed for targeted modulation of the protein for oncology and autoimmune research. The company specializes in the research and development of oncology medicines that render the growth hormone receptor dysfunctional, making the cells less sensitive to growth hormone, as seen in the syndrome, enabling healthcare researchers and biopharmaceutical developers to pursue more precise therapeutic strategies for complex malignancies and immune-driven disorders.

Contact Information

Website
www.biminibiotech.nl
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Langegracht 70
  • Zuid-Holland
  • 2312 NV Leiden
  • Netherlands
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Langegracht 70
  • Zuid-Holland
  • 2312 NV Leiden
  • Netherlands

BIMINI Biotech Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BIMINI Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Seed Round 08-Jan-2025 $3.13M Completed Startup
9. Accelerator/Incubator Completed Startup
8. Seed Round 12-Apr-2023 Completed Startup
7. Grant 17-Dec-2022 Completed Startup
6. Early Stage VC 01-Apr-2021 Completed Startup
5. Debt - General 26-Nov-2020 Completed Startup
4. Grant 09-Oct-2020 Completed Startup
3. Grant 18-Mar-2020 Completed Startup
2. Seed Round Completed Startup
1. Accelerator/Incubator Completed Startup
To view BIMINI Biotech’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

BIMINI Biotech Patents

  • 2

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

BIMINI Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3811945-A1 Compounds for treating and preventing growth hormone receptor-dependent conditions Inactive 25-Oct-2019
WO-2021078995-A1 Selective polypeptide synthesis stalling assay and compound Inactive 25-Oct-2019

BIMINI Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BIMINI Biotech Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Torrey Pines Investment Venture Capital Minority
InnovationQuarter Venture Capital Minority
Massachusetts Institute of Technology Endowment Limited Partner
Libertatis Ergo Holding (LEH) Venture Capital Minority
UNIIQ Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

Ready to get started?

Request a free trial

BIMINI Biotech FAQs

  • When was BIMINI Biotech founded?

    BIMINI Biotech was founded in 2019.

  • Where is BIMINI Biotech headquartered?

    BIMINI Biotech is headquartered in Leiden, Netherlands.

  • What is the size of BIMINI Biotech?

    BIMINI Biotech has 9 total employees.

  • What industry is BIMINI Biotech in?

    BIMINI Biotech’s primary industry is Drug Discovery.

  • Is BIMINI Biotech a private or public company?

    BIMINI Biotech is a Private company.

  • What is BIMINI Biotech’s current revenue?

    The current revenue for BIMINI Biotech is .

  • How much funding has BIMINI Biotech raised over time?

    BIMINI Biotech has raised $3.89M.

  • Who are BIMINI Biotech’s investors?

    Torrey Pines Investment, InnovationQuarter, Massachusetts Institute of Technology Endowment, Libertatis Ergo Holding (LEH), and UNIIQ are 5 of 10 investors who have invested in BIMINI Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process